Vor Biopharma
VOR
VOR
58 hedge funds and large institutions have $188M invested in Vor Biopharma in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
48% less capital invested
Capital invested by funds: $362M → $188M (-$174M)
Holders
58
Holding in Top 10
2
Calls
$13K
Puts
–
Top Buyers
| 1 | +$1.6M | |
| 2 | +$283K | |
| 3 | +$255K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$198K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$151K |
Top Sellers
| 1 | -$1.76M | |
| 2 | -$734K | |
| 3 | -$458K | |
| 4 |
BlackRock
New York
|
-$327K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$252K |